Component

AMPylated GLUD1

GLUD1 modified by covalent AMP attachment; distinct from free AMP.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. AMPylation decreased GLUD1 enzymatic activity in the tested assays.

    AMPylated GLUD1 → GLUD1 source_derived_draftliterature_reviewed:direct_experimental
    Experimental context and source evidence
    cell_type
    experimental assay
    experimental_model
    Modified-enzyme activity measurements
    limitations
    No human dietary response established.
    organism
    mammalian

    Selenium: literature corrections and mechanism additions · lines 498–508

    Metabolic Ledger literature curation, 17 September 2026; primary papers linked individually · supports · Modified-enzyme activity measurements · secondary_verified · secondary_verified

    ## glud1-ampylation-decreases-activity The AMP modification reduced GLUD1 activity in these experiments. AMPylation decreased GLUD1 enzymatic activity in the tested assays. Organism: mammalian Cell type: experimental assay Experimental model: Modified-enzyme activity measurements Limitations: No human dietary response established. Primary reference: [A repurposed AMP binding domain reveals mitochondrial protein AMPylation as a regulator of cellular metabolism](https://www.nature.com/articles/s41467-025-63014-z)
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. SELENOO catalyzes AMP attachment to GLUD1.

    SELENOO → GLUD1 source_derived_draftliterature_reviewed:direct_experimental
    Experimental context and source evidence
    cell_type
    experimental cells
    experimental_model
    Biochemical AMPylation assays
    limitations
    Substrate identification does not establish every tissue context.
    organism
    mammalian

    Selenium: literature corrections and mechanism additions · lines 486–496

    Metabolic Ledger literature curation, 17 September 2026; primary papers linked individually · supports · Biochemical AMPylation assays · secondary_verified · secondary_verified

    ## selenoo-ampylates-glud1 SELENOO can modify the metabolic enzyme GLUD1 with AMP. SELENOO catalyzes AMP attachment to GLUD1. Organism: mammalian Cell type: experimental cells Experimental model: Biochemical AMPylation assays Limitations: Substrate identification does not establish every tissue context. Primary reference: [A repurposed AMP binding domain reveals mitochondrial protein AMPylation as a regulator of cellular metabolism](https://www.nature.com/articles/s41467-025-63014-z)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards